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Abstract
Background: Persons with type 1 diabetes who use electronic self-help tools most commonly blood glucose meters and record
a large amount of data about their personal condition. Mobile phones are powerful and ubiquitous computers that have a
potential for data analysis, and the purpose of this study is to explore how self-gathered data can help users improve their
blood glucose management.
Subjects and Methods: Thirty patients with insulin-regulated type 1 diabetes were equipped with a mobile phone application
for 3–6 months, recording blood glucose, insulin, dietary information, physical activity, and disease symptoms. The data
were analyzed in terms of usage of the different modules and which data processing and visualization tools could be
constructed to support the use of these data.
Results: Eighteen patients (denoted ‘‘adopters’’) recorded complete data for over 80 consecutive days, up to 247 days. Among
those who withdrew or did not use the application extensively, the most common reasons given were outdated or difficult-to-
use phone. Data analysis using period finding and scale-space trends was found to yield significant patterns for most
adopters. Pattern recognition methods to predict low or high blood glucose were found to be performing poorly.
Conclusions: Minimally intrusive mobile applications enable users with type 1 diabetes to record data that can provide data-
driven feedback to the user, potentially providing relevant insight into their disease.
Introduction
Type 1 diabetes (T1D) is a chronic disease that requiresconsiderable effort by the afflicted patients to control
their blood glucose level. Recent technological advances have
provided better devices and tools, bringing patients closer to
closed-loop and artificial pancreas solutions.1,2 Nevertheless,
a large percentage of patients still use paper-based methods to
track their blood glucose and related factors in multiple daily
injections of insulin regimens combined with self-measured
blood glucose (SMBG).
Physiological and metabolic models of the interactions
among blood glucose, insulin, diet, and other factors are
useful as decision tools for patients.3 Computational methods
including mathematical models tend to be based on contin-
uous glucose meters (CGMs), which measure the glucose level
in the subcutaneous tissue. Because CGMs do not measure in
the blood directly, there is a significant delay and more in-
accurate measurements, particularly during critical periods of
quickly decreasing blood glucose levels or with improper
calibration or sensor fixation. The vast amount of data pro-
vided by CGMs provides rich datasets for modeling. Pro-
viding patients with CGMs seems to enable better glycemic
control and lower glycated hemoglobin (HbA1c), particularly
in patients with high baseline HbA1c.3,4 Compared with the
simplicity of SMBG, however, CGMs are a very resource-
intensive and expensive solution for many patients.
Glycemic variability is considered an important clinical
variable for T1D patients.5 There are several measures of
variability, such as the commonly used dropmean b AU1amplitude
of glycemic excursions. Quantifying variability using SMBG
values is typically done using SD even though the values are
generally not normally distributed. The correspondences be-
tween the different measures of variability are not clear.6
Using information technologies as tools for patients with
chronic diseases is effective if they are used properly; in par-
ticular, intelligent decision support systems have proved to be
promising.7 Numerous tools using mobile technology to
support patients with diabetes exist, either alone or in com-
bination with online services.8,9 Using mobile phones as a
communications tool for people with diabetes has been
shown effective,10 and using mobile phone technology in
conjunction with telemedical support improves HbA1c lev-
els.11 Given the large amount of data assembled by T1D
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patients and the ubiquitous nature of these devices, utilizing
phones’ computational power for data analysis and visuali-
zation is a natural step forward.9
At the Norwegian Centre for Integrated Care and Tele-
medicine (Tromsø, Norway), a diabetes diary known as the
Few Touch Application (FTA) has been developed as a re-
search tool for self-management intended for both T1D and
type 2 diabetes (T2D) patients. The version for T2D is mature
and has been tested both in pilot groups and in a large-scale
randomized controlled trial.12 The version for T1D used in the
present study includes recording of insulin, symptoms, and
comments but is otherwise identical to the T2D version.13 In
this open-ended study, patients were encouraged to use the
diary as part of their daily life, thus accumulating a realistic
dataset. The data from these patients were assembled and
analyzed with the aim of identifying which data analysis
methods could realistically be used and could provide
meaningful feedback to the user.
Determining relevant clinical patterns for patients can
provide them with meaningful insight into relevant parame-
ters of their own disease and provide a foundation for dis-
cussion with healthcare personnel. Predictive models based
on CGMs are widespread, whereas similar models for SMBG
are rare because of the relative sparsity of the data. Detecting
patterns that lead to unwanted situations can provide useful
feedback to patients so that these situations can be avoided.
Trend detection is another potentially useful modality of
data-driven feedback. A user with a mean blood glucose level
that is too high should ideally change this situation by
achieving a long-term decreasing glucose trend. Typically,
users lack tools to detect such patterns and to associate them
with personal lifestyle or habits.
Subjects and Methods
We developed a version of the FTA for T1D based on
previous experience with T2D versions and prototyping and
from a previous T1D study.14 The T1D version comprises a
function for easy recording of insulin injections together with
nutrition, options for commenting on all data, and an im-
proved feedback screen where the user sees blood glucose,
insulin injections, and food intake in relation to each other.
The application was developed on the Windows mobile ver-
sion 6.5 operating system, and the patients were given an
HTC (Taoyuan City, Taiwan) HD mini mobile phone for use
during the trial. In b F1Figure 1 we show some screenshots from
the application used. The system for recording food intake
consisted of six categories of food: low carbohydrate snack,
high carbohydrate snack, low carbohydrate drink, high car-
bohydrate drink, low carbohydrate meal, and high carbohy-
drate meal (see Fig. 1C for the user interface).
For the study we recruited 30 persons with T1D who were
attending the Department of Endocrinology at the University
Hospital of North Norway (Tromsø). The recruitment was
performed at the discretion of the diabetes nurses and medical
doctors. Five of the recruited patients used CGMs along with
the FTA.
The patients were instructed to use the application in the way
that suited their needs and preferences but were encouraged to
measure blood glucose at least three times a day, to record their
insulin injections, their nutritional intake, their physical activity,
and symptoms of other diseases or discomfort, and to set per-
sonal goals for nutrition and physical activity. The patients were
invited to meetings at 1, 3, and 6 months (unless they withdrew
from the study), where we downloaded data from their mobile
phone diaries and the patients gave their feedback on the user
interface and other aspects of the application, blood glucose
measuring system, and the mobile phone.
Analysis
The data were analyzed in terms of usage using regression
coefficients to test for significant characteristics correlating
with patient’s usage of the FTA.
The recorded data were mined to find useful methods for
modeling and prediction. The identified methods and their
background are reported in Results.
All statistical analysis was done using R.15
Results
Of the 30 patients recruited, three actively withdrew from
the study before 3 months. Two of these individuals provided
FIG. 1. Screenshots
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from the Few Touch Application. From left to right, (A) the main screen with all basic options, (B)
recording of insulin dose with editable time (default current time), (C) Registration of food and drink into six categories, (D)
overview list of last activities, with normal blood glucose in green, high glucose in yellow, low glucose in red, food or drink in
blue, and insulin in white, and (E) graph with the last glucose measurements.
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the data they had recorded up to the time of withdrawal.
Three additional patients’ data were lost to the study for
various reasons, meaning that 24 patients followed through to
the 3-month follow-up. All patients were given the opportu-
nity to continue using the equipment for a further 3-month
period; 19 patients accepted this and were followed up for a
total of 6 months. Not all patients used the equipment actively
during the period they had it.
Usage
As a measure of overall usage, we used the total number of
blood glucose measurements, insulin injections recorded, and
food items recorded in the period. The results for each patient
are summarized inF2 c Figure 2. Because physical activity and
symptoms were recorded to a significantly lower degree
(compare Fig. 2), we did not use these data in the analysis. To
test for covariates we used a linear regression model on sex,
age, and prestudy HbA1c. Results show that usage was pos-
itively correlated with age (regression coefficient, 55.8 re-
cordings/year; P = 0.009). Usage was not significantly
correlated with prestudy HbA1c (P = 0.34) or sex (P = 0.10).
There was no change in mean HbA1c for the cohort or any
correlation between HbA1c and any parameters of usage.
There was no significant change in weight over the course of
the study or any correlation between change in weight and
usage parameters.
For further analysis, we divided the patients into two dis-
joint groups: ‘‘adopters’’ and ‘‘nonadopters.’’ The adopters
were 18 patients who recorded data reliably (i.e., without
considerable interruptions) for at least 80 days. The patient
characteristics of the two groups are shown inT1 c Table 1. For the
adopters, usage of blood glucose, insulin, and food mea-
surements was relatively frequent and stable. It is notable, as
can be seen in Figure 2, that there was much variation in the
usage among patients within the adopter group.
Periodicities
The uneven sampling rate of the SMBG measurements al-
lows for period detection at frequencies above the Nyquist
frequency by using periodograms for unevenly sampled data
such as the Lomb–Scargle periodogram.16,17 The Lomb–
Scargle periodogram is a linear best fit to a sine curve with the
given period and arbitrary phase. Using the fact that the
power is exponentially distributed one can find the signifi-
cance of the period. If a significant period is identified, this can
be visualized to the user for example in the form of a
smoothed kernel regression curve over the given period.18
We searched for periodicities in the complete data from all
adopters by computing the Lomb–Scargle periodogram for the
FIG. 2. Usage statistics for all recruited patients who contributed any data. Each column is, from the bottom to the top, the
number of recordings in the logs for blood glucose (n.BG), insulin, activity, and food, respectively. The patients classified as
adopters are denoted with a dot at the low end of the column. The patients are grouped into three groups according to overall
period of usage time T as measured from first to last entry in the Few Touch Application. Five users with no data are not
shown. Color graphics available online at www.liebertonline.com/dia
Table 1. Patients Characteristics








Age years [mean (SD)] 39.1 (11.2) 32.9 (10.0) 43.2 (10.3)
Female (%) 13 (43.3) 4 (33.3) 9 (50)
HbA1c (%) [mean (SD)] at
Start 8.3 (1.4) 8.7 (1.7) 8.1 (1.2)
End 8.3 (1.3) 8.9 (1.1) 8.1 (1.3)
HbA1c, glycated hemoglobin.
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period ranges 24 – 1 h, 168 – 24 h (weekly), and 720 – 150 h (30
days/month), and we identified the most significant peak in
each range. If the most significant peak occurs at a frequency f
and has power P( f ), the P value is approximated as p = e–P( f ). To
confirm the validity of this assumption we performed Monte
Carlo tests for a few selected values and found good agreement.
InT2 c Table 2, the significance of periodicities on a daily,
weekly and monthly basis for each patient in the adopter
group is shown. Because we used the same data to test for
three different periodicities, we corrected the significance
levels by Bonferroni’s correction, such that a 0.05 overall
significance level corresponds to a 0.05/3 = 0.017 individual
significance level. Thus, any patient who has a significant
periodicity has consistent sine-like variation with that period.
For instance, a patient’s blood glucose level may be typically
higher in the evenings, which will emerge as a significant
periodicity after data from a certain number of days are re-
corded. The pattern can subsequently be visualized to the
patient so that the patient can be informed and make appro-
priate changes or discuss the pattern with his or her physician.
For visualization of the periodic pattern, we use kernel
regression smoothing with a fixed bandwidth. It is still nec-
essary to display an indication of the error because this will
typically vary. In particular, there are likely to be few mea-
surements (and high error) during the night. The nightly
measurements may also carry higher bias because patients are
more likely to wake up and measure their blood glucose when
it is outside the normal range.
Pattern recognition
Using and fine-tuning pattern recognition methods is la-
borious, but despite our best efforts we could not find any
technique that performed substantially better than random at
predicting future blood glucose values based on statistical
learning techniques.19 We also constructed a three-way clas-
sification problem for the classes low, high, and normal range,
which is a simpler problem compared with predictive re-
gression. The limits of the ranges of each class were deter-
mined individually in the training set by the 20% and 80%
quantiles in order to avoid empty training sets. Thus, the
classes did not necessarily reflect medical hypo- or hyper-
glycemia, but rather unusually low or high blood glucose
values. The classifier was trained on the data recorded up to
the current time and predicted the probability of low or high
glucose at the next blood glucose measurement. If a pattern
that indicated low blood glucose was identified, for example,
the important predictors could be presented to the user, en-
abling the user to learn from typical undesirable situations
that had not been identified previously.
The results indicate that pattern recognition methods for
prediction or predictive classification are not useful for these
data. We tested several different classifiers, including random
forests, support vector machines, and quadratic discriminant
analysis. We found that generally support vector machines
with a radial kernel function performed the best of these, in-
cluding providing the best balancing of the classes. However,
the classification was not good enough to provide meaningful
insight from the feature selection (i.e., we could not discrim-
inate which features were important for classification). We
performed two independent binary classifications for the
problems low versus not low and high versus not high, and
whenever there were conflicting results for any data point, the
prediction was set to the normal range. Thus we could com-
pute the precision and recall for the results, and the corre-
sponding points in the receiver operating characteristics plot
shown in b F3Figure 3 for both problems. Although most results
Table 2. Estimated P Values for Each Periodicity
and Each Patient
P number Daily Weekly Monthly
1 0.0057 (24 h)b 0.051 (185 h) —
2 < 10 - 5 (24 h)b < 10 - 5 (168 h)b 0.00015 (730 h)b
3 0.00063 (24 h)b 0.012 (149 h)a —
6 < 10 - 5 (24 h)b 0.0033 (170 h)b 0.058 (614 h)
7 0.00040 (24 h)b 0.0057 (165 h)a —
8 < 10 - 5 (24 h)b 0.0086 (166 h)a —
10 0.00006 (23.6 h)b 0.039 (191 h) 0.090 (671 h)
12 < 10 - 5 (24 h)b 0.0061 (145 h)a —
14 < 10 - 5 (24.2 h)b 0.0015 (165 h)b 0.0026 (670 h)b
15 < 10 - 5 (24 h)b 0.00089 (152 h)b 0.0048 (701 h)a
16 0.00018 (24 h)b 0.0070 (166 h)a 0.00078 (728 h)b
20 < 10 - 5 (24 h)b 0.0033 (144 h)a 0.019 (743 h)
22 < 10 - 5 (24.1 h)b < 10 - 5 (153 h)b < 10 - 5 (852 h)b
26 < 10 - 5 (23.9 h)b 0.00088 (177 h)b 0.00011 (645 h)b
28 < 10 - 5 (24 h)b 0.00024 (171 h)b 0.00092 (847 h)b
29 < 10 - 5 (24 h)b 0.041 (157 h) —
30 < 10 - 5 (24.1 h)b 0.0010 (168 h)b 0.047 (705 h)
A dash indicates where no significant peak with P < 0.1 was found.
Numbers in parentheses indicate the period at which the spectral
maximum is, where we have searched within 24 – 1 h, 168 – 24 h, and
720 – 150 h, respectively.
aP < 0.05/3, bP < 0.01/3.
FIG. 3. Receiver operating characteristics plot for classifi-
cation of low or high blood glucose using support vector
machines with a radial kernel function. Gray dots indicate
high glucose (80% quantile), black dots low glucose (20%
quantile), and each dot corresponds to one patient. The di-
agonal line shows the random classifier, points closer to the
upper left corner than the diagonal line mean improved
classification over random guessing. Color graphics available
online at www.liebertonline.com/dia
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were above the non-discrimination diagonal line, they were
only slightly better than random guessing. The best prediction
results were for hyperglycemia, performing somewhat better
than the best hypoglycemia results.
Significant change points
The large amount of noise in the SMBG measurements
makes it difficult to identify trends apart from obvious ones
when a simple scatterplot is presented such as in the current
version of FTA (Fig. 1A). SMBG values are not necessarily an
unbiased sampling of actual blood glucose because mea-
surements typically are preprandial or measured when the
user suspects low or high blood glucose values. Nevertheless,
trends in the measured values can be valuable as indicators of
physiological change.
An appropriate tool to identify changes in live systems is
the c-SiZer algorithm, which detects changes very early and at
any scale of observation (S.O. Skrøvseth, J.G. Bellika, and F.
Godtliebsen, ‘‘Causality in scale space as an approach to
change detection,’’ manuscript submitted for publication).
The latter property is important because trends may appear at
FIG. 4. Significant scale-space trends for three selected patients. Gray dots are blood glucose measurements, the y-axis is
cropped for visibility,
4C c
and black vertical lines indicate measurements above the selected range. Black smooth lines are kernel
regression functions using linear least squares regression with a quartic kernel function and bandwidths in hours as indicated
in the individual panels. Red segments show a significant decreasing trend at the given scale, and blue segments indicate a
significant increasing trend. The scales shown are chosen based on the full c-SiZer plots such that most significant trends are
shown, although some details on the very smallest scales are omitted for clarity. Bandwidth is here defined as half of the
support of the kernel.
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distinct scales simultaneously. For example, a user may ex-
perience a short-term significant increase in blood glucose as
part of a long-term significant decrease. c-SiZer allows for
detection and visualization of these trends as they appear.
c-SiZer is based on the SiZer (Significant Zero-crossings of
derivatives) methodology, which defines a scale space span-
ned by a bandwidth and time and performs a hypothesis test
of the derivative of the signal at every point in scale space.20
c-SiZer is a causal version that is adapted for live processes
such as sensor data.21 Thus changes can be detected live
during data acquisition and presented to the user.
All adopters had significant trends at some point, most
commonly on smaller scales, typically of one or a few hours.
Large-scale trends on several days or more also appeared in
most patients.
Example of three patients’ time series and significant trends
are shown inF4 c Figure 4. All these patients exhibit trends on both
small and large scales. Although some trends are significant at
several scales, in most cases a trend appears on only one of the
selected scales. On a few occasions there are also conflicting
trends (i.e., a significant increasing trend on one scale may
overlap with a significant decreasing trend on another scale).
There is no contradiction in this because long-term trends
inevitably contain small-scale variations that may themselves
be significant.
Discussion
We have presented three distinct methods for analysis and
presentation of data recorded, primarily blood glucose mea-
surements, by the FTA system. Even with a platform that is
designed to be as nonintrusive as possible, the data quality is
usable for some particular feedback algorithms.
The poor performance of the pattern recognition is likely to
be largely caused by the low fidelity of the food recording. The
system has a minimally functional food recording system in
which the users themselves are free to define which foods go
into which categories. Thus, the correspondence between
carbohydrate content and food categorization is minimal,
while all other nutritional information is absent. In future
versions of the FTA we will experiment with implementing
carbohydrate counting, analogous to recent commercial de-
vices. Providing feedback on variability to patients could
potentially be another useful feature, but given the un-
certainties there is no unambiguous way to implement such
features based on SMBG data.
The FTA itself has proven a valuable tool for T2D patients,
and the current study shows that it is also useful for T1D
patients, with the majority of the users actively using the de-
vice for a long period. Although some of the extended usage is
likely to be explained as a Hawthorne or novelty effect, it is
probable that each of these would wear off over the study
period. We find little evidence of that given that usage patterns
are consistent over the whole period for the active patients. In
this study, the FTA was implemented on Windows Mobile 6.5
phones, which were already outdated at the point of the study.
This was a common source of complaint among the users,
particularly those accustomed to more modern devices or
systems such as Android- or iOS-based devices. The applica-
tion is currently being improved and developed on the An-
droid system, and the effect of both platform and device on
user satisfaction and adherence is being investigated.
For all applications a significant amount of training of the
patients has to be performed. A user cannot be expected to
understand the ideas immediately. Once minimal training has
been performed and visualized feedback becomes available,
the motivation to improve the quality of the recordings can be
substantiated and thus initiate a positive feedback loop from
the patient’s perspective.
When trends and periodicities are presented to a user, the
results will be provided in real time with only those properties
that are currently relevant and significant visible to the user.
Thus the display will be simplified and will not always have
any pattern displayed.
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